TB-500 (thymosin beta-4) What the research shows TB-500 is the synthetic peptide commonly marketed as, and derived from, thymosin beta-4 (T4), an actin-binding protein studied for wound healing and angiogenesis
They started tirzepatide six months ago and only now notice increased shedding, so they blame stress, seasonal changes, or aging instead of recognizing the medication-triggered pattern
Additionally, these fatty acids help rebalance vital neurotransmitters, such as serotonin and dopamine, essential for the functioning of the trigeminovascular nociceptive pathway, and can inhibit TNF- expression, potentially reducing cerebral vasodilation implicated in migraine episodes
These reports, while not scientifically rigorous, are numerous and consistent